Exact Sciences is developing a blood-based screening method for colorectal cancer. Samples collected from the BLUE-C clinical trial will be used to establish the performance characteristics of this test. A blood test will be another addition to our portfolio of colorectal cancer screening options to reach the 44 million Americans who need to be screened for colorectal cancer.
Interested?
If you are interested in this item and have some questions, feel free send an inquiry.
Click Here
On the Go?
Scan our QR code and use your phone to access our catalog.Text EXACTSCI to 866-866-5545
Exact Sciences is a proud member of
Southern Arizona Hispanic Business Marketplace
Click Here to Learn MoreCommunity Sponsors